Recent advances in intravenous anaesthesia

British Journal of Anaesthesia

Volumn 93, Issue 5, 2004, Pages 725-736

  Sneyd, J Robert ^a  

^a UNIVERSITY OF PLYMOUTH   (United Kingdom)

Author keywords

Anaesthetics i.v., etomidate; Anaesthetics i.v., ketamine; Anaesthetics i.v., ORG21465; Anaesthetics i.v., ORG25435; Anaesthetics i.v., propofol; Anaesthetics i.v., THRX 918661; Analgesics opioid, remifentanil

Indexed keywords

ALFENTANIL; AM149; AMPOFOL; AQUAVAN; CYCLODEXTRIN; DOLASETRON MESILATE; EMLA; EPHEDRINE; ETOMIDATE; FENTANYL; GRANISETRON; INTRAVENOUS ANESTHETIC AGENT; ISOFLURANE; KETAMINE; KETOROLAC; LIDOCAINE; MAGNESIUM SULFATE; METOCLOPRAMIDE; MIDAZOLAM; MORPHINE; NAFAMSTAT MESILATE; NEOSTIGMINE; NITROUS OXIDE; ONDANSETRON; OPIATE; POLYSORBATE 80; PRILOCAINE; PROPOFOL; REMIFENTANIL; THIOPENTAL; TRAMADOL; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANALGESIC ACTIVITY; BRADYCARDIA; CONTROLLED RELEASE FORMULATION; DISEASE EXACERBATION; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG CONTRAINDICATION; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG HALF LIFE; DRUG HYPERSENSITIVITY; DRUG METABOLISM; DRUG POTENCY; DRUG POTENTIATION; DRUG SAFETY; DRUG SOLUBILITY; DRUG TOLERABILITY; ELECTROENCEPHALOGRAM; HUMAN; INJECTION PAIN; INTRAVENOUS ANESTHESIA; MEDICAL RESEARCH; MYOTONIA; NONHUMAN; PARKINSON DISEASE; PEDIATRIC ANESTHESIA; PHARMACODYNAMICS; POSTOPERATIVE PAIN; POSTOPERATIVE VOMITING; PRIORITY JOURNAL; REVIEW; SEDATION; SURGICAL PATIENT;

EID: 7444234860     PISSN: 00070912     EISSN: None     Source Type: Journal    
DOI: 10.1093/bja/aeh253     Document Type: Review

References (134)

1. Absalom A, Amutike D, Lal A, White M, Kenny GN. Accuracy of the 'Paedfusor' in children undergoing cardiac surgery or catheterization. Br J Anaesth 2003; 91: 507-13
2. Absalom AR, Kenny GN. Closed-loop control of propofol anaesthesia using bispectral index(TM): performance assessment in patients receiving computer-controlled propofol and manually controlled remifentanil infusions for minor surgery. Br J Anaesth 2003; 90 737-41
3. Alexander R, Booth J, Olufolabi AJ, El-Moalem HE, Glass PS. Comparison of remifentanil with alfentanil or suxamethonium following propofol anaesthesia for tracheal intubation. Anaesthesia 1999; 54: 1032-6
4. Altomare C, Trapani G, Latrofa A, et al. Highly water-soluble derivatives of the anesthetic agent propofol: in vitro and in vivo evaluation of cyclic amino acid esters. Eur J Pharm Sci 2003; 20: 17-26
5. Anderson BJ, Marks PV, Futter ME. Propofol-contrasting effects in movement disorders. Br J Neurosurg 1994; 8: 387-8
6. Angel A, Arnott RH, Linkers DA, Ting CH. Somatosensory evoked potentials for closed-loop control of anaesthetic depth using propofol in the urethane-anaesthetized rat. Br J Anaesth 2000; 85: 431-9
7. Anis AH, Wang XH, Leon H, Hall R. Economic evaluation of propofol for sedation of patients admitted to intensive care units. Anesthesiology 2002; 96: 196-201
8. Apfel CC, Kranke P, Katz MH, et al. Volatile anaesthetics may be the main cause of early but not delayed postoperative vomiting: a randomized controlled trial of factorial design. Br J Anaesth 2002; 88: 659-68
9. Apfel CC, Korttila K, Abdalla M, et al. A factorial trial of six interventions for the prevention of postoperative nausea and vomiting. N Engl J Med 2004; 350: 2441-51
10. Badrinath S, Avramov MN, Shadrick M, Witt TR, Ivankovich AD. The use of a ketamine-propofol combination during monitored anesthesia care. Anesth Analg 2000; 90: 858-62
11. Bailey JM. Context-sensitive half-times: what are they and how valuable are they in anaesthesiology? Clin Pharmacokinet 2002; 41: 793-9
12. Baker MT, Dehring DJ, Gregerson MS. Sulfite supported lipid peroxidation in propofol emulsions. Anesthesiology 2002; 97: 1162-7
13. Baker MT, Gregerson MS, Martin SM, Buettner GR. Free radical and drug oxidation products in an intensive care unit sedative: propofol with sulfite. Crit Care Med 2003; 31: 787-92
14. Banaszczyk MG, Carlo AT, Milian V, et al. Propofol phosphate, a water-soluble propofol prodrug: in vivo evaluation. Anesth Analg 2002; 95: 1285-92
15. Beamish D, Brown DT. Adverse responses to i.v. anaesthetics. Br J Anaesth 1981; 53: 55-8
16. Beattie D, Jenkins T, McCullough J, et al. The in vivo activity of THRX-918661, a novel, pharmacokinetically responsive sedative/hypnotic agent. Anaesthesia 2004; 59: 101
17. Bedard J M, Richardson MG, Wissler RN. General anesthesia with remifentanil for Cesarean section in a parturient with an acoustic neuroma. Can J Anaesth 1999; 46: 576-80
18. Bennett DJ, Anderson A, Buchanan K, et al. Novel water soluble 2,6-dimethoxyphenyl ester derivatives with intravenous anaesthetic activity. Bioorg Med Chem Lett 2003; 13: 1971-5
19. Bettschart-Wolfensberger R, Semder A, Alibhai H, Demuth D, Aliabadi FS, Clarke KW. Cardiopulmonary side-effects and pharmacokinetics of an emulsion of propofol (Disoprivan) in comparison to propofol solved in polysorbate 80 in goats. J Vet Med A Physiol Pathol Clin Med 2000; 47: 341-50
20. Blair JM, Hill DA, Fee JP. Patient-controlled analgesia for labour using remifentanil: a feasibility study. Br J Anaesth 2001; 87: 415-20
21. Bourgoin A, Albanese J, Wereszczynski N, Charbit M, Vialet R, Martin C. Safety of sedation with ketamine in severe head injury patients: comparison with sufentanil. Crit Care Med 2003; 31: 711-7
22. Bowdle TA, Camporesi EM, Maysick L, et al. A multicenter evaluation of remifentanil for early postoperative analgesia. Anesth Analg 1996; 83: 1292-7
23. Bowdle TA, Ready LB, Kharasch ED, Nichols WW, Cox K. Transition to post-operative epidural or patient-controlled intravenous analgesia following total intravenous anaesthesia with remifentanil and propofol for abdominal surgery. Eur J Anaesthesiol 1997; 14: 374-9
24. Bowler I, Djaiani G, Abel R, Pugh S, Dunne J, Hall J. A combination of intrathecal morphine and remifentanil anesthesia for fast-track cardiac anesthesia and surgery. J Cardiothorac Vasc Anesth 2002; 16: 709-14
25. Cavaliere F, Antonelli M, Arcangeli A, et al. A low-dose remifentanil infusion is well tolerated for sedation in mechanically ventilated, critically-ill patients. Can J Anaesth 2002; 49: 1088-94
26. Celleno D, Capogna G, Tomassetti M, Costantino P, Di Feo G, Nisini R. Neurobehavioural effects of propofol on the neonate following elective Caesarean section. Br J Anaesth 1989; 62: 649-54
27. Cooke A, Anderson A, Buchanan K, et al. Water-soluble propofol analogues with intravenous anaesthetic activity. Bioorg Med Chem Lett 2001; 11: 927-30
28. De Castro V, Godet G, Mencia G, Raux M, Coriat P. Target-controlled infusion for remifentanil in vascular patients improves hemodynamics and decreases remifentanil requirement. Anesth Analg 2003; 96: 33-8
29. Doufas AG, Bakhshandeh M, Bjorksten AR, Greif R, Sessler DI. A new system to target the effect-site during propofol sedation. Acta Anaesthesiol Scand 2003; 47: 944-50
30. Durieux ME. Editorial I: Powerful tools require careful handling - the case of the circadian ketamine effect. Br J Anaesth 2004; 92: 783-92
31. Egan TD. Target-controlled drug delivery: progress toward an intravenous 'vaporizer' and automated anesthetic administration. Anesthesiology 2003; 99: 1214-9
32. Egan TD, Kern SE, Johnson KB, Pace NL. The pharmacokinetics and pharmacodynamics of propofol in a modified cyclodextrin formulation (Captisol) versus propofol in a lipid formulation (Diprivan): an electroencephalograph ic and hemodynamic study in a porcine model. Anesth Analg 2003; 97: 72-9
33. Egan TD, Shafer SL. Target-controlled infusions for intravenous anesthetics: surfing USA not! Anesthesiology 2003; 99: 1039-41
34. Egan TD, Shafer SL, Jenkins TE, Beattie DT, Jaw-Tsai SS. The pharmacokinetics and pharmacodynamics of THRX-918661, a novel sedative/hypnotic agent. Anesthesiology 2003; 99: A516
35. Fechner J, Ihmsen H, Hatterscheid D, et al. Pharmacokinetics and clinical pharmacodynamics of the new propofol prodrug GPI 15715 in volunteers. Anesthesiology 2003; 99: 303-13
36. Gan TJ, Meyer T, Apfel CC, et al. Consensus guidelines for managing postoperative nausea and vomiting. Anesth Analg 2003; 97: 62-71
37. Gepts E, Camu F, Cockshott ID, Douglas EJ. Disposition of propofol administered as constant rate intravenous infusions in humans. Anesth Analg 1987; 66: 1256-63
38. Glen JB, Hunter SC. Pharmacology of an emulsion formulation of ICI 35 868. Br J Anaesth 1984; 56: 617-26
39. Guignard B, Coste C, Costes H, et al. Supplementing desflurane-remifentanil anesthesia with small-dose ketamine reduces perioperative opioid analgesic requirements. Anesth Analg 2002; 95: 103-8
40. Habib AS, Parker JL, Maguire AM, Rowbotham DJ, Thompson JP. Effects of remifentanil and alfentanil on the cardiovascular responses to induction of anaesthesia and tracheal intubation in the elderly. BrJ Anaesth 2002; 88: 430-3
41. Hall AP, Thompson JP, Leslie NA, Fox AJ, Kumar N, Rowbotham DJ. Comparison of different doses of remifentanil on the cardiovascular response to laryngoscopy and tracheal intubation. Br J Anaesth 2000; 84: 100-2
42. Hart B. 'Diprivan': a change of formulation. Eur J Anaesthesiol 2000; 17: 71-3
43. Hijazi Y, Bodonian C, Bolon M, Salord F, Boulieu R. Pharmacokinetics and haemodynamics of ketamine in intensive care patients with brain or spinal cord injury. Br J Anaesth 2003; 90: 155-60
44. Hocking G, Cousins MJ. Ketamine in chronic pain management: an evidence-based review. Anesth Analg 2003; 97: 1730-9
45. Hogue CWJ, Bowdle TA, O'Leary C, et al. A multicenter evaluation of total intravenous anesthesia with remifentanil and propofol for elective inpatient surgery. Anesth Analg 1996; 83: 279-85
46. Hoymork SC, Raeder J, Grimsmo B, Steen PA. Bispectral index, serum drug concentrations and emergence associated with individually adjusted target-controlled infusions of remifentanil and propofol for laparoscopic surgery. Br J Anaesth 2003; 91: 773-80
47. Hug CC, Jr, McLeskey CH, Nahrwold ML, et al. Hemodynamic effects of propofol: data from over 25,000 patients. Anesth Analg 1993; 77: S21-9
48. Hull CJ, Van Beem HB, McLeod K, Sibbald A, Watson MJ. A pharmacodynamic model for pancuronium. Br J Anaesth 1978; 50: 1113-23
49. Jaksch W, Lang S, Reichhalter R, Raab G, Dann K, Fitzal S. Perioperative small-dose S(+)-ketamine has no incremental beneficial effects on postoperative pain when standard-practice opioid infusions are used. Anesth Analg 2002; 94: 981-6
50. Jenkins T, Beattie D, Jaw-Tsai S, et al. THRX-918661, a novel, pharmacokinetically responsive sedative/hypnotic agent. Anaesthesia 2004; 59: 100
51. Jenkins TE, Axt S, Bolton J, inventors. Short-acting sedative hypnotic agents for anesthesia and sedation. USA patent 20030153554.2003
52. Johannsen EK, Munro AJ. Remifentanil in emergency caesarean section in pre-eclampsia complicated by thrombocytopenia and abnormal liver function. Anaesth Intensive Care 1999; 27: 527-9
53. Kan RE, Hughes SC, Rosen MA, Kessin C, Preston PG, Lobo EP. Intravenous remifentanil: placental transfer, maternal and neonatal effects. Anesthesiology 1998; 88: 1467-74
54. Kazama T, Ikeda K, Morita K, et al. Comparison of the effect-site k(eO)s of propofol for blood pressure and EEG bispectral index in elderly and younger patients. Anesthesiology 1999; 90 1517-27
55. Kazama T, Kurita T, Morita K, Nakata J, Sato S. Influence of hemorrhage on propofol pseudo-steady state concentration. Anesthesiology 2002; 97: 1156-61
56. Kissin I, Bright CA, Bradley EL, Jr. The effect of ketamine on opioid-induced acute tolerance: can it explain reduction of opioid consumption with ketamine-opioid analgesic combinations? Anesth Analg 2000; 91: 1483-8
57. -1 in critically ill, mechanically ventilated patients. Acta Anaesthesiol Scand 2004; 48: 302-7
58. Laxenaire MC, Gueant JL, Bermejo E, Mouton C, Navez MT. Anaphylactic shock due to propofol. Lancet 1988; 2: 739-40
59. Laxenaire MC, Mata-Bermejo E, Moneret-Vautrin DA, Gueant JL. Life-threatening anaphylactoid reactions to propofol (Diprivan). Anesthesiology 1992; 77: 275-80
60. Maguire AM, Kumar N, Parker JL, Rowbotham DJ, Thompson JP. Comparison of effects of remifentanil and alfentanil on cardiovascular response to tracheal intubation in hypertensive patients. Br J Anaesth 2001; 86: 90-3
61. Marsh B, White M, Morton N, Kenny GN. Pharmacokinetic model driven infusion of propofol in children. Br J Anaesth 1991; 67 41-8
62. Martindale SJ, Dix P, Stoddart PA. Double-blind randomized controlled trial of caudal versus intravenous S(+)-ketamine for supplementation of caudal analgesia in children. Br J Anaesth 2004; 92: 344-7
63. McCarroll CP, Paxton LD, Elliott P, Wilson DB. Use of remifentanil in a patient with peripartum cardiomyopathy requiring Caesarean section. Br J Anaesth 2001; 86: 135-8
64. Mertens E, Saldien V, Coppejans H, Bettens K, Vercauteren M. Target controlled infusion of remifentanil and propofol for cesarean section in a patient with multivalvular disease and severe pulmonary hypertension. Acta Anaesthesiol Belg 2001; 52: 207-9
65. Mertes PM, Laxenaire MC. Unrecognised fatal reaction to propofol or fentanyl. Anaesthesia 2002; 57: 821-2
66. Milne SE, Kenny GN, Schraag S. Propofol sparing effect of remifentanil using closed-loop anaesthesia. Br J Anaesth 2003; 90: 623-9
67. Minkowitz HS. Postoperative pain management in patients undergoing major surgery after remifentanil vs. fentanyl anesthesia. Multicentre Investigator Group. Can J Anaesth 2000; 47: 522-8
68. Minto CF, Schnider TW, Shafer SL. Pharmacokinetics and pharmacodynamics of remifentanil. II. Model application. Anesthesiology 1997; 86: 24-33
69. Minto CF, Schnider TW, Gregg KM, Henthorn TK, Shafer SL. Using the time of maximum effect site concentration to combine pharmacokinetics and pharmacodynamics. Anesthesiology 2003; 99 324-33
70. Munjal M, Sood D, Gupta VK, Singh A, Kaul TK. Use of vegetarian propofol in Jain community of India. Anaesthesia 2003; 58: 1137
71. Munoz HR, Guerrero ME, Brandes V, Cortinez LI. Effect of timing of morphine administration during remifentanil-based anaesthesia on early recovery from anaesthesia and postoperative pain. Br J Anaesth 2002; 88: 814-8
72. Murdoch CJ, Crooks BA, Miller CD. Effect of the addition of ketamine to morphine in patient-controlled analgesia. Anaesthesia 2002; 57: 484-8
73. Murdoch JA, Hyde RA, Kenny GN. Target-controlled remifentanil in combination with propofol for spontaneously breathing day-case patients. Anaesthesia 1999; 54: 1028-31
74. Nau C, Strichartz GR. Drug chirality in anesthesia. Anesthesiology 2002; 97: 497-502
75. Nicholson G, Pereira AC, Hall GM. Parkinson's disease and anaesthesia. Br J Anaesth 2002; 89: 904-16
76. Olufolabi AJ, Booth JV, Wakeling HG, Glass PS, Penning DH, Reynolds JD. A preliminary investigation of remifentanil as a labor analgesic. Anesth Analg 2000; 91: 606-8
77. Paul M, Dueck M, Kampe S, Fruendt H, Kasper SM. Pharmacological characteristics and side effects of a new galenic formulation of propofol without soyabean oil. Anaesthesia 2003; 58: 1056-62
78. Peacock JE, Lewis RP, Reilly CS, Nimmo WS. Effect of different rates of infusion of propofol for induction of anaesthesia in elderly patients. Br J Anaesth 1990; 65: 346-52
79. Peacock JE, Luntley JB, O'Connor B, et al. Remifentanil in combination with propofol for spontaneous ventilation anaesthesia. Br J Anaesth 1998; 80: 509-11
80. Pees C, Haas NA, Ewert P, Berger F, Lange PE. Comparison of analgesic/sedative effect of racemic ketamine and S(+)-ketamine during cardiac catheterization in newborns and children. Pediatric Cardiology 2003; 24: 424-9
81. Pitsiu M, Wilmer A, Bodenham A, et al. Pharmacokinetics of remifentanil and its major metabolite, remifentanil acid, in ICU patients with renal impairment. Br J Anaesth 2004; 92: 493-503
82. Rau J, Roizen MF, Doenicke AW, O'Connor MF, Strohschneider U. Propofol in an emulsion of long- and medium-chain triglycerides: the effect on pain. Anesth Analg 2001; 93: 382-4
83. Reeves M, Lindholm DE, Myles PS, Fletcher H, Hunt JO. Adding ketamine to morphine for patient-controlled analgesia after major abdominal surgery: a double-blinded, randomized controlled trial. Anesth Analg 2001; 93: 116-20
84. Rieschke P, LaFleur BJ, Janicki PK. Effects of EDTA- and sulfite-containing formulations of propofol on respiratory system resistance after tracheal intubation in smokers. Anesthesiology 2003; 98: 323-8
85. Rigby-Jones AE, Nolan JA, Priston MJ, Wright PM, Sneyd JR, Wolf AR. Pharmacokinetics of propofol infusions in critically ill neonates, infants, and children in an intensive care unit. Anesthesiology 2002; 97: 1393-400
86. Roelants F, De Franceschi E, Veyckemans F, Lavand-homme P. Patient-controlled intravenous analgesia using remifentanil in the parturient. Can J Anaesth 2001; 48: 175-8
87. Rowbotham DJ, Peacock JE, Jones RM, et al. Comparison of remifentanil in combination with isoflurane or propofol for short-stay surgical procedures. Br J Anaesth 1998; 80: 752-5
88. Sakuragi T, Yanagisawa K, Shirai Y, Dan K. Growth of Escherichia coli in propofol, lidocaine, and mixtures of propofol and lidocaine. Acta Anaesthesiol Scand 1999; 43: 476-9
89. Sanders JC. Paediatric regional anaesthesia, a survey of practice in the United Kingdom. Br J Anaesth 2002; 89: 707-10
90. Sato Y, Kobayashi E, Hakamata Y, et al. Chronopharmacological studies of ketamine in normal and NMDA epsilon1 receptor knockout mice. Br J Anaesth 2004; 92: 859-64
91. Schmid R, Koren G, Klein J, Katz J. The stability of a ketamine- morphine solution. Anesth Analg 2002; 94: 898-900
92. Schnider TW, Shafer SL. Evolving clinically useful predictors of recovery from intravenous anesthetics. Anesthesiology 1995; 83: 902-5
93. Schuttler J, Ihmsen H. Population pharmacokinetics of propofol: a multicenter study. Anesthesiology 2000; 92: 727-38
94. Schuttler J, Ihmsen H. Population pharmacokinetics of propofol for target-controlled infusion (TCI) in the elderly. Anesthesiology 2000; 93: 1558-60
95. Scott H, Bateman C, Price M. The use of remifentanil in general anaesthesia for caesarean section in a patient with mitral valve disease. Anaesthesia 1998; 53: 695-7
96. Scott H, Bateman C, Price M. The use of remifentanil in general anaesthesia for caesarean section in a patient with mitral valve disease. Anaesthesia 1998; 53: 695-7
97. Scott RP, Saunders DA, Norman J. Propofol: clinical strategies for preventing the pain of injection. Anaesthesia 1988; 43: 492-4
98. Shafer SL. Stanford PK/PD Software Server. In: http://anesthesia. stanford.edu/pkpd/; 2004
99. Shao X, Li H, White PF, Klein KW, Kulstad C, Owens A. Bisulfite-containing propofol: is it a cost-effective alternative to Diprivan for induction of anesthesia? Anesth Analg 2000; 91: 871-5
100. Sheiner LB, Stanski DR, Vozeh S, Miller RD, Ham J. Simultaneous modeling of pharmacokinetics and pharmacodynamics: application to d-tubocurarine. Clin Pharmacol Ther 1979; 25: 358-71
101. Sneyd JR. Excitatory events associated with propofol anaesthesia: a review. J Roy Soc Med 1992; 85: 288-91
102. Sneyd JR, Wright PCM, Cross M, et al. Administration to man of ORG 21465 a water soluble steroid intravenous anaesthetic agent. Br J Anaesth 1997; 79: 427-32
103. Sneyd JR, Wright PM, Harris D, et al. Computer-controlled infusion of ORG 21465, a water soluble steroid i.v. anaesthetic agent, into human volunteers. Br J Anaesth 1997; 79 433-9
104. Sneyd JR, Carr A, Byrom WD, Bilski AJ. A meta-analysis of nausea and vomiting following maintenance of anaesthesia with propofol or inhalational agents. Eur J Anaesthesiol 1998; 15: 433-45
105. Sneyd JR. Propofol and epilepsy. Br J Anaesth 1999; 82: 168-9
106. Sneyd JR, Tsubokawa T, Andrews CJH, et al. First administration to man of ORG25435, a new intravenous anaesthetic agent. Br J Anaesth 2001; 86: 323P
107. Sneyd JR. Remifentanil manual versus target-controlled infusion. Anesth Analg 2003; 97: 300
108. Song D, Hamza M, White PF, Klein K, Recart A, Khodaparast O. The pharmacodynamic effects of a lower-lipid emulsion of propofol: a comparison with the standard propofol emulsion. Anesth Analg 2004; 98: 687-91
109. Song D, Hamza MA, White PF, Byerly SI, Jones SB, Macaluso AD. Comparison of a lower-lipid propofol emulsion with the standard emulsion for sedation during monitored anesthesia care. Anesthesiology 2004; 100: 1072-5
110. Streisand JB, Jaarsma RL, Gay MA, et al. Oral transmucosal etomidate in volunteers. Anesthesiology 1998; 88 89-95
111. Struys MM, De Smet T, Depoorter B, et al. Comparison of plasma compartment versus two methods for effect compartment-controlled target-controlled infusion for propofol. Anesthesiology 2000; 92 399-406
112. Struys MM, De Smet T, Versichelen LF, Van De Velde S, Van den Broecke R, Mortier EP. Comparison of closed-loop controlled administration of propofol using Bispectral Index as the controlled variable versus 'standard practice' controlled administration. Anesthesiology 2001; 95: 6-17
113. Theilen HJ, Adam S, Albrecht MD, Ragaller M. Propofol in a medium- and long-chain triglyceride emulsion: pharmacological characteristics and potential beneficial effects. Anesth Analg 2002; 95: 923-9
114. Thurlow JA, Waterhouse P. Patient-controlled analgesia in labour using remifentanil in two parturients with platelet abnormalities. Br J Anaesth 2000; 84: 411-3
115. Tramer M, Moore A, McQuay H. Meta-analytic comparison of prophylactic antiemetic efficacy for postoperative nausea and vomiting: propofol anaesthesia vs omitting nitrous oxide vs total i.v. anaesthesia with propofol. Br J Anaesth 1997; 78: 256-9
116. Trapani A, Laquintana V, Lopedota A, et al. Evaluation of new propofol aqueous solutions for intravenous anesthesia. Int J Pharm 2004; 278: 91-8
117. Tzabazis A, Ihmsen H, Schywalsky M, Schwilden H. EEG-controlled closed-loop dosing of propofol in rats. Br J Anaesth 2004; 92: 564-9
118. Unlugenc H, Ozalevli M, Guler T, Isik G. Postoperative pain management with intravenous patient-controlled morphine: comparison of the effect of adding magnesium or ketamine. Eur J Anaesthesiol 2003; 20: 416-21
119. Upton RN, Ludbrook GL, Grant C, Martinez AM. Cardiac output is a determinant of the initial concentrations of propofol after short-infusion administration. Anesth Analg 1999; 89: 545-52
120. Vijn PC, Sneyd JR. I.V. anaesthesia and EEG burst suppression in rats: bolus injections and closed-loop infusions. Br J Anaesth 1998; 81: 415-21
121. Vinik HR, Kissin I. Rapid development of tolerance to analgesia during remifentanil infusion in humans. Anesth Analg 1998; 86: 1307-11
122. Volmanen P, Akural EI, Raudaskoski T, Alahuhta S. Remifentanil in obstetric analgesia: a dose-finding study. Anesth Analg 2002; 94: 913-7
123. Vuyk J, Schnider TP, Engbers F. Population pharmacokinetics of propofol for target-controlled infusion (TCI) in the elderly. Anesthesiology 2000; 93: 1557-8
124. Wakeling HG, Zimmerman JB, Howell S, Glass PS. Targeting effect compartment or central compartment concentration of propofol: what predicts loss of consciousness? Anesthesiology 1999; 90: 92-7
125. Ward DS, Norton JR, Guivarc'h PH, Litman RS, Bailey PL. Pharmacodynamics and pharmacokinetics of propofol in a medium-chain triglyceride emulsion. Anesthesiology 2002; 97: 1401-8
126. Weber F, Wulf H. Caudal bupivacaine and s(+)-ketamine for postoperative analgesia in children. Paediatr Anaesth 2003; 13 244-8
127. Weber F, Wulf H, el Saeidi G. Premedication with nasal s-ketamine and midazolam provides good conditions for induction of anesthesia in preschool children. Can J Anesth 2003; 50: 470-5
128. Weinbroum AA. A single small dose of postoperative ketamine provides rapid and sustained improvement in morphine analgesia in the presence of morphine-resistant pain. Anesth Analg 2003; 96: 789-95
129. Wiel E, Davette M, Carpentier L, et al. Comparison of remifentanil and alfentanil during anaesthesia for patients undergoing direct laryngoscopy without intubation. Br J Anaesth 2003; 91 421-3
130. Yau G, Gin T, Ewart MC, Kotur CF, Leung RK, Oh TE. Propofol for induction and maintenance of anaesthesia at caesarean section. A comparison with thiopentone/enflurane. Anaesthesia 1991; 46: 20-3
131. Zaloga GP, Marik P. Sulfite-induced propofol oxidation: a cause for radical concern. Crit Care Med 2003; 31: 981-3
132. Zarate E, Sa Rego MM, White PF, et al. Comparison of adenosine and remifentanil infusions as adjuvants to desflurane anesthesia. Anesthesiology 1999; 90 : 956-63
133. Zhang J, Maland L, Hague B, et al. Buccal absorption of etomidate from a solid formulation in dogs. Anesth Analg 1998; 86: 1116-22
134. Kazama T, Morita K, Ikeda T, Kurita T, Sato S. Comparison of predicted induction dose with predetermined physiologic characteristics of patients and with pharmacokinetic models incorporating those characteristics as covariates. Anesthesiology 2003; 98: 299-305